Increased levels of cardiac troponin-T in outpatients with heart failure and preserved systolic function are related to adverse clinical findings and outcome

Coronary Artery Disease

Volumn 17, Issue 8, 2006, Pages 685-691

  Macin, Stella M ^a   Perna, Eduardo R ^a   Cimbaro Canella, Juan P ^a   Augier, Natalia ^a   Riera Stival, Jorge L ^a   Cialzeta, Jorge ^a   Pitzus, Ariel E ^a   Obregon, Ricardo ^a   Garcia, Edgar ^a   Medina, Fernanda ^a   Badaracco, Reynaldo J ^a  

^a Instituto de Cardiología de Corrientes Juana F Cabral   (Argentina)

Author keywords

Heart failure; Myocardial injury; Preserved systolic function; Prognosis

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE; TROPONIN C;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION TEST; HEART INJURY; HOSPITALIZATION; HUMAN; IMMUNOASSAY; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

AGED; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; OUTPATIENTS; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SYSTOLE; TROPONIN T;

EID: 33845571576     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mca.0000236287.56435.14     Document Type: Article

References (38)

1. Choudhury L, Gheorghiade M, Bonow R. Coronary artery disease in patients with heart failure and preserved systolic function. Am J Cardiol 2002; 89:719-722.
2. Kitzman D. Theraphy for diastolic heart failure: on the road from myths to multicenter trials. J Card Fail 2001; 7:229-231.
3. Vasan R, Levy D. Defining diastolic heart failure. A call for standardized diagnostic criteria. Circulation 2000; 10:2118-2121.
4. Caruana L, Petrie MC, Davie AP, Mc Murray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from diastolic heart failure or from misdiagnosis? A prospective descriptive study. BMJ 2000; 321:215-218.
5. Kitzman DW, Gardian JM, Gottdiener JS, Arnold AM, Boineau R, Aurigemma GP, et al. For the Cardiovascular Health Study Group: importance of heart failure with preserved systolic function in patients >65 years of age. Am J Cardiol 2001; 87:413-419.
6. Ansari M, Alexander M, Tutar A, Massie B. Incident cases of heart failure in a community cohort: importance and outcomes of patients with preserved systolic function. Am Heart J 2003; 146:115-120.
7. Pernenkil R, Vinson JM, Shah A, Beckman V, Wittenberg C, Rich MW. Course and prognostic in ≥ 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 1997; 79:216-219.
8. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part I diagnosis, prognosis, and measurements of diastolic function. Circulation 2002; 105:1387-1393.
9. Sato Y, Kita T, Takatsu Y, Kimura T. Biochemical markers of myocyte injury in heart failure. Heart 2004; 90:1110-1113.
10. Del Carlo C, O'Connor CH. Cardiac troponins in congestive heart failure. Am Heart J 1999; 138:646-653.
11. Perna ER, Macin SM, Cimbaro Canella JP, Alvarenga PM, Pantich RE, Rios NG, et al. High levels of troponin T are associated with ventricular remodeling and adverse in-hospital outcome in heart failure. Med Sci Monit 2004; 10:CR90-CR95.
12. Setsuta K, Seino Y, Takahashi N, Ogawa T, Sasaki K, Harada A, et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 1999; 84:608-611.
13. Perna ER, Macin SM, Cimbaro Canella JP, Augier N, Stival JL, Cialzeta JR, et al. Ongoing myocardial injury in stable severe heart failure. Value of cardiac Troponin T monitoring for high-risk patient identification. Circulation 2004; 110:2376-2382.
14. Macin SM, Perna ER, Cimbaro Canella JP, Moratorio DA, Alvarenga PM, Augier N, et al. Clinical profile and myocardial damage detected by cardiac troponin T in patients with heart failure due to systolic or diastolic heart failure (abstract). J Card Fail 2002; 1:34.
15. Badano LP, Albanese MC, De Biaggio P, Rozbowsky P, Miani D, Fresco C, et al. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular. J Am Soc Echocardiogr 2004; 17:253-261.
16. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004; 43:317-327.
17. Tsutsui H, Tsuchihashi M, Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol 2001; 88:530-533.
18. Dauterman KW, Massie BM, Gheorghiade M. Heart failure associated with preserved systolic function: a common and costly clinical entity. Am Heart J 1998; 135:S310-S319.
19. Macin SM, Perna ER, Cimbaro Canella JP, Alvarenga P, Pantich R, Rios N, et al. Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function. Rev Esp Cardiol 2004; 57:45-52.
20. Potluri S, Ventura HO, Mulumudi M, Mehra MR. Cardiac troponin levels in heart failure. Cardiol Rev 2004; 12:21-25.
21. Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM. Spectrum of heart failure in older patients: results from the national heart failure project. Am Heart J 2002; 143:412-417.
22. Gottdiener JS, Arnold AM, Aurigemma G. Predictors of congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol 2000; 35:1628-1637.
23. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, et al. It's time for a change to a troponin standard. Circulation 2000; 102:1216-1220.
24. Horwich TB, Patel J, MacLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamic, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003; 108:833-838.
25. Perna ER, Macin SM, Parras JI, Pantich R, Farias EF, Badaracco JR, et al. Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema. Am Heart J 2002; 143:814-820.
26. Löwbeer C, Gustafsson SA, Seeberger A, Bouvier F, Hulting J. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction. Scand J Clin Lab Invest 2004; 64:667-676.
27. Unverferth DV, Magorien RD, Lewis RP, Leier CV. The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. Am Heart J 1983; 105:176-179.
28. Solaro RJ. Troponin I, stunning, hypertrophy, and failure of the heart. Circ Res 1999; 84:122-124.
29. Lopez B, Gonzalez A, Varo N, Laviades C, Querejeta R, Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 2001; 38:1222-1226.
30. Kass DA, Bronzwaer JG, Paulus WJ. What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 2004; 94:1533-1542.
31. Uretsky BF, Thygesen K, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, et al. Acute coronary findings at autopsy in heart failure patients with sudden death. Results from the Assessment of Treatment With Lisinopril and Survival (ATLAS) Trial. Circulation 2000; 102:611-616.
32. Perna ER, Cimbaro Canella JP, Macin SM. Importance of myocardial damage in acute decompensated heart failure: changing the paradigm from a passive to an active process. Minerva Cardioangiol 2005;53:523-535.
33. Garcia EH, Perna ER, Farias EF, Obregon RO, Macin SM, Parras JI, et al. Reduced systolic performance by tissue doppler in patients with preserved and abnormal ejection fraction: new insights in chronic heart failure. Int J Cardiol 2006;108:181-188.
34. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure. Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 2006;113:986-994.
35. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. The EuroHeart Failure survey programme a survey on the quality of care among patients with heart failure in Europe. Part 1: patients characteristics and diagnosis. Eur Heart J 2003; 24:442-463.
36. Ishii J, Nomura M, Nakamura Y, Naruse H, Mori Y, Ishikawa T, et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 2002; 89:691-695.
37. Angeja BG, Grossman W. Evaluation and management of diastolic heart failure. Circulation 2003; 107:659-660.
38. Al-Mallah MH, Tleyjeh IM, Abdel-Latif AA, Weaver WD. Angiotensin- converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol 2006; 47:1576-1583.